ルイジアナ州における子宮内膜がんの臨床試験
ルイジアナ州内の拠点で、子宮内膜がんに関する15件の研究が参加者を募集しています。
ルイジアナ州内の都市
公式研究テキスト（英語）
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- West Jefferson Medical Center, Marrero
- East Jefferson General Hospital, Metairie
- LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
- 他1件
被験者募集中第3相
18歳以上 · 女性 · 2026/10/05更新 · NCT07198074Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Ochsner Medical Center Jefferson, New Orleans
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Ochsner Clinic Foundation, New Orleans
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/29更新 · NCT05051722Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- University Medical Center New Orleans, New Orleans
被験者募集中第2相
18歳以上 · 女性 · 2026/09/24更新 · NCT05640999A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- WK Cancer Center, Shreveport
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT06340568A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Women's Cancer Care ( Site 6010), Covington
- TRIALS 365 ( Site 6005), Shreveport
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT06952504ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Tulane Cancer Center, New Orleans
- Christus Highland/ Boniol, Shreveport
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- OLOL Cancer Institute, Baton Rouge
- Trials365, LLC, Shreveport
被験者募集中第3相
18歳以上 · 女性 · 2026/09/09更新 · NCT07166094DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Shreveport
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06989112A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- LSU Health Sciences, New Orleans
- Trials365, LLC, Shreveport
被験者募集中第2相
18歳以上 · 女性 · 2026/08/21更新 · NCT05548296A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Our Lady of the Lake, Baton Rouge
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Trials365 LLC, Shreveport
被験者募集中第3相
18歳以上 · 女性 · 2026/07/28更新 · NCT07022483First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Louisiana State University Health Sciences Center, New Orleans
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Ochsner MD Anderson Cancer Center, New Orleans
被験者募集中第2相
18歳以上 · 女性 · 2026/06/02更新 · NCT06730347SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。